Jason Karch
- Molecular Biology top 5%
- Cardiology and Cardiovascular Medicine top 2%
- Surgery top 5%
- Epidemiology top 10%
- Oncology top 10%
- Co-authors
- Jeffery D. MolkentinOnur KanisicakRonald J. VagnozziHadi KhalilRobert N. CorrellMichelle A. SargentMatthew J. BrodyBryan D. Maliken
- Topics
- Mitochondrial Function and Pathology (18 papers)ATP Synthase and ATPases Research (7 papers)Cell death mechanisms and regulation (6 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Jason Karch
34 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 2.5k
- Cardiology and Cardiovascular Medicine 1.2k
- Surgery 821
- Epidemiology 356
- Oncology 350
Countries citing papers authored by Jason Karch
This map shows the geographic impact of Jason Karch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Karch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Karch more than expected).
Fields of papers citing papers by Jason Karch
This network shows the impact of papers produced by Jason Karch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Karch. The network helps show where Jason Karch may publish in the future.
Co-authorship network of co-authors of Jason Karch
This figure shows the co-authorship network connecting the top 25 collaborators of Jason Karch. A scholar is included among the top collaborators of Jason Karch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Karch. Jason Karch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injurybreakdown → | 53 |
| 3 | 4 | |
| 4 | 1 | |
| 5 | Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directionsbreakdown → | 195 |
| 6 | 10 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 103 | |
| 10 | 10 | |
| 11 | 11 | |
| 12 | 29 | |
| 13 | 176 | |
| 14 | 42 | |
| 15 | Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosisbreakdown → | 673 |
| 16 | Genetic lineage tracing defines myofibroblast origin and function in the injured heartbreakdown → | 640 |
| 17 | 86 | |
| 18 | 131 | |
| 19 | 45 | |
| 20 | 30 |
About Jason Karch
Jason Karch is a scholar working on Clinical Biochemistry, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 3.7k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (18 papers), ATP Synthase and ATPases Research (7 papers) and Cell death mechanisms and regulation (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Molecular Biology (2.5k citations) and Clinical Biochemistry (155 citations). Jason Karch has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Jeffery D. Molkentin, Onur Kanisicak, Ronald J. Vagnozzi, Hadi Khalil, Robert N. Correll, Michelle A. Sargent, Matthew J. Brody, Bryan D. Maliken, Tobias G. Schips and Marjorie Maillet. Their work appears in journals such as Nature, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.